NCT04874402

Brief Summary

The purpose of this study is to investigate the to analyze the patient satisfaction and complication rates under controlled conditions of the increasingly popular prepectoral technique for implant-based breast reconstruction.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 5, 2021

Completed
2.4 years until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

June 18, 2023

Status Verified

June 1, 2023

Enrollment Period

9 months

First QC Date

April 30, 2021

Last Update Submit

June 15, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Patient satisfaction as measured by BREAST-Q-scores

    Patient satisfaction will be assessed using BREAST-Q-scores. BREAST-Q is a patient-reported outcome instrument used to assess the outcomes of different breast surgeries among women. Modules selected will be "Psychosocial Well-Being, Physical Well-Being: Chest and Satisfaction with Breasts" within the Reconstruction (Preoperative) module and "Psychosocial Well-Being, Physical Well-Being: Chest, Satisfaction with Breasts and Satisfaction with Implants" within the Reconstruction (Postoperative) module For each BRESAT-Q scale, items are summed and transformed to a score with range from 0 to 100, and with greater values representing more satisfaction and higher levels of breast related quality of life. A two-sample T-test will be used to assess the changes in mean scores of satisfaction between two arms

    Preoperatively

  • Patient satisfaction as measured by BREAST-Q-scores

    Patient satisfaction will be assessed using BREAST-Q-scores. BREAST-Q is a patient-reported outcome instrument used to assess the outcomes of different breast surgeries among women. Modules selected will be "Psychosocial Well-Being, Physical Well-Being: Chest and Satisfaction with Breasts" within the Reconstruction (Preoperative) module and "Psychosocial Well-Being, Physical Well-Being: Chest, Satisfaction with Breasts and Satisfaction with Implants" within the Reconstruction (Postoperative) module For each BRESAT-Q scale, items are summed and transformed to a score with range from 0 to 100, and with greater values representing more satisfaction and higher levels of breast related quality of life. A two-sample T-test will be used to assess the changes in mean scores of satisfaction between two arms

    postoperative day 90 +/-30 days

Secondary Outcomes (15)

  • Overall complication rates

    Preoperatively

  • Overall complication rates

    Postoperative day 1

  • Overall complication rates

    Postoperative day 7 +/-7 days

  • Overall complication rates

    Postoperative day 14 +/-7 days

  • Overall complication rates

    postoperative day 21 +/-7 days

  • +10 more secondary outcomes

Study Arms (2)

Prepectoral approach

ACTIVE COMPARATOR

Immediately following mastectomy, participants will undergo prepectoral reconstruction approach. Intraoperative filling volume will be decided by the attending surgeon based on the pocket dimension and volume capabilities. Participants will be evaluated at 6 time points during the study.

Procedure: Prepectoral approach

Partial subpectoral approach

EXPERIMENTAL

Immediately following mastectomy, participants will undergo partial subpectoral reconstruction approach. Intraoperative filling volume will be decided by the attending surgeon based on the pocket dimension and volume capabilities. Participants will be evaluated at 6 time points during the study.

Procedure: Partial Subpectoral approach

Interventions

Two sheets of contour, fenestrated ADM sutured together are trimmed in accordance with the measurement of the expander/implant and fixed to the pectoralis major muscle (superiorly, medially, and inferiorly) and serratus fascia (laterally), covering the entire anterior surface of the device

Prepectoral approach

The leading edge of the pectoral muscle is elevated and a subpectoral pocket is fashioned. The lower medial origin muscle fibers are released for anatomical expander seating. An ADM sling is sutured from the leading edge of the pectoralis muscle to the inframammary fold (over the expander) and laterally to close the expander pocket. In both groups, the size of the expander and the intraoperative filling volume will be decided by the attending surgeon based on the pocket dimension and volume capabilities.

Partial subpectoral approach

Eligibility Criteria

Age19 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Undergoing two-stage implant-based breast reconstruction for either breast cancer or breast cancer risk reduction

You may not qualify if:

  • Active use of any tobacco products
  • Uncontrolled diabetes defined by HbA1c greater than 7.5%
  • Class II obesity or higher defined by a body mass index equal or greater than 35 kg/m2
  • History of radiation to the affect breast or chest
  • Immunocompromised patients
  • Clinical evidence of significant mastectomy flap ischemia prior to the initiation of the reconstructive procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Florida, Case Comprehensive Cancer Center

Weston, Florida, 33331, United States

Location

Study Officials

  • Amir Ghaznavi, MD

    Cleveland Clinic Florida, Case Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2021

First Posted

May 5, 2021

Study Start

October 1, 2023

Primary Completion

June 30, 2024

Study Completion

June 30, 2025

Last Updated

June 18, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

No plans to share IPD

Locations